About this Research Topic
The global prevalence of diabetes continues to rise, projected to impact 700 million individuals by 2045. This increase parallels a significant growth in diabetes-associated complications, with diabetic retinopathy (DR) emerging as one of the most challenging due to its impact on vision and quality of life. Currently, DR is the leading cause of preventable blindness among working-age adults worldwide, with around 22% of individuals with diabetes experiencing some level of DR, and over 10% facing vision-threatening stages. Key risk factors for DR development and progression include prolonged hyperglycemia, hypertension, and diabetes duration. Advances in early detection, including AI-based screening systems, and therapeutic interventions have offered new hope. However, the persistence of DR as a major cause of blindness underscores the need for ongoing research in preventive and therapeutic strategies.
This collection seeks to tackle pressing questions in the prevention and treatment of diabetic retinopathy, with the goal of reducing the incidence of blindness and improving quality of life for patients with diabetes. The aim is to explore innovative approaches that address gaps in early intervention, optimize current treatment options, and investigate emerging therapeutic modalities for DR. By gathering these studies, this collection aims to consolidate current advancements in DR prevention and treatment, offering insights to mitigate the burden of DR and improve patient outcomes in diabetes care. To achieve this, this collection aims to attract the following, sub themes:
• Early Detection and Prevention: Highlight innovative strategies for early DR detection, including AI-based screening tools and lifestyle interventions to delay disease onset.
• Therapeutic Advances: Evaluate established and emerging treatments, including anti-VEGF, laser therapy, steroids, and surgical interventions, to optimize DR management.
• Technological and Pharmacological Innovations: Examine cutting-edge approaches in AI and personalized medicine to improve treatment precision and patient outcomes.
This collection seeks to tackle pressing questions in the prevention and treatment of diabetic retinopathy, with the goal of reducing the incidence of blindness and improving quality of life for patients with diabetes. The aim is to explore innovative approaches that address gaps in early intervention, optimize current treatment options, and investigate emerging therapeutic modalities for DR. By gathering these studies, this collection aims to consolidate current advancements in DR prevention and treatment, offering insights to mitigate the burden of DR and improve patient outcomes in diabetes care. To achieve this, this collection aims to attract the following, sub themes:
• Early Detection and Prevention: Highlight innovative strategies for early DR detection, including AI-based screening tools and lifestyle interventions to delay disease onset.
• Therapeutic Advances: Evaluate established and emerging treatments, including anti-VEGF, laser therapy, steroids, and surgical interventions, to optimize DR management.
• Technological and Pharmacological Innovations: Examine cutting-edge approaches in AI and personalized medicine to improve treatment precision and patient outcomes.
Keywords: Diabetic, Retinopathy, Treatment, Therapeutics, Prevention, Technology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
